Mavacamten in obstructive hypertrophic cardiomyopathy - Are beta-blockers blocking part of its shine?

Eur J Heart Fail. 2023 Feb;25(2):271-273. doi: 10.1002/ejhf.2768. Epub 2023 Jan 11.

Authors

Fernando Dominguez^{1

2}, Eva Cabrera¹

Affiliations

¹ Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitario Puerta de Hierro Madrid, Madrid, Spain.
² Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

PMID: 36597820
DOI: 10.1002/ejhf.2768

No abstract available

Publication types

Editorial
Comment

MeSH terms

Adrenergic beta-Antagonists
Benzylamines
Cardiomyopathy, Hypertrophic*
Heart Failure*
Humans

Substances

MYK-461
Adrenergic beta-Antagonists
Benzylamines